Industry Workshops provide an opportunity for AMCP corporate members (commercial organizations) to showcase their latest drug therapies, technologies, and a wealth of products and services affecting professionals working in managed care pharmacy.
Materials presented in workshops may be promotional and concentrate on a specific product, service, or therapeutic area. Therefore, these presentations are considered promotional and do not offer continuing education credit.
Industry Workshop presentations are scheduled during AMCP 2021 Virtual on Wednesday, April 14 from 9:30-10:30am.
Emerging Treatment Data for Patients With SMA
Sponsored by Biogen
Spinal muscular atrophy (SMA) is a neurodegenerative disease that is characterized by progressive muscle weakness resulting from the degeneration of motor neurons in the spinal cord. For patients with SMA, this can lead to reduced mobility and decreased survival in the most severe cases. Timely and effective intervention remains important, as disease progression is highly variable among patients with SMA and motor function loss may become permanent. In this session, we will describe a treatment option for SMA, the benefits of therapeutic intervention, and associated efficacy and safety data. [This program is open only to representatives of payers, formulary committees, or other similar entities who have responsibility for the selection of drugs for coverage or reimbursement.]
James Wymer, MD, PhD, FAAN, University of Florida Neurology
Management of Two Subsets of Challenging to Treat Major Depressive Disorder (MDD) in Adults
Sponsored by Janssen Pharmaceuticals, Inc.
Expert-led presentation of the unmet need of adult patients with two subsets of challenging to treat major depressive disorder (MDD) and review of current coverage challenges when providing a treatment option in these patient populations. There will be a 15-minute Q&A session at the end of the presentation.
Craig Chepke, MD, FAPA, Adjunct Associate Professor of Psychiatry, Atrium Health Wake Forest School of Medicine, Adjunct Assistant Professor of Psychiatry, University of North Carolina School of Medicine, and Medical Director, Excel Psychiatric Associates